NewsWhore
09-19-2008, 09:30 PM
issued a compulsory license to produce a lower-cost version of the drug after rejecting Merck's offer to sell the drug at a 30% discount, which would have lowered the price from $1.57 per dose to $1.1...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/17918230/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/17918230/)